News

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of unfulfilled requirements, and the increasing significance of technology like pharmacogenomics, digital therapies, and artificial intelligence are what propel activity....

The creation of a tool that can enable organic chemical processes that were not possible before has given the pharmaceutical business new ways to make effective drugs more quickly. In the past, most drugs were put together using alkyl building...

Richard Lee, Director, Core Technology and Capabilities, ACD/Labs, says that integrating machine learning (ML) and artificial intelligence (AI) in pharmaceutical R&D means getting past problems with data management, quality, and expertise in order to use them to their full...

Even sophisticated scientific approaches have problems. For challenging solvents, liquid and gas chromatography (LC and GC), the gold standard for analysis and separations, might yield limited insights. Molecular rotational resonance (MRR) is fast becoming commonplace since it may offer...

Quick delivery of toxicological materials According to Alejandro Fernandez Martell and James Berrie from Lonza, a bottleneck has developed in the supply of toxicological data to support INDs for novel therapies and, therefore, delivery of FIH studies, as a result...

Polycarbonate plastic, which is produced through the use of the well-studied, building-block chemistry known as Bisphenol A, or BPA, plays an important role in the field of healthcare and medical devices, particularly in hospitals, neonatal units, and surgical facilities....

Understanding the Impact of Extractables and Leachables (E&L) on Drug Safety Extractables and leachables (E&L) pose two primary risks: contamination from harmful impurities like nitrosamine or chromium, which can cause toxicity, and the reduction of drug efficacy due to destabilization...